Tourangeau Greg

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Tourangeau Greg's trades of Fulcrum Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
280.91
Quantity 28,977
Value US$1,429,041
Transaction date
Proposed sale
Price
11.72
Quantity 4,884
Value US$57,218
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-09-02
PrS Proposed sale
28,977
280.91
US$1,429,041 		28,977 280.91 US$1,429,041
2025-05-09 2025-05-08
PlS Planned sale
11,525 +25.0%
214.26
US$1,017,223 		11,525 +25.0% 214.26 US$1,017,223
2024-05-09 2024-05-07
S Sale
40,528 +7.7%
312.53
US$1,917,693 		40,528 +7.7% 312.53 US$1,917,693
2024-03-08 2024-03-08
PrS Proposed sale
4,884
11.72
US$57,218 		4,884 11.72 US$57,218
2024-03-08 2024-03-08
PlS Planned sale
4,884 -29.3%
11.72
US$57,219 		4,884 -29.3% 11.72 US$57,219
2023-05-11 2023-05-10
S Sale
210 -1.3%
3.31
US$695 		210 -1.3% 3.31 US$695